Truncal acne, what do we know?
Journal
Journal of the European Academy of Dermatology and Venereology : JEADV
ISSN: 1468-3083
Titre abrégé: J Eur Acad Dermatol Venereol
Pays: England
ID NLM: 9216037
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
received:
25
02
2020
accepted:
30
04
2020
pubmed:
19
5
2020
medline:
15
5
2021
entrez:
19
5
2020
Statut:
ppublish
Résumé
Truncal acne is frequently overlooked in dermatological practice, even though it may result in scars and impact on self-esteem and body image. Therefore, it is important to identify the disease early in order to initiate treatment in time and, thus, to prevent it from worsening and resulting in physical and psychological sequelae. The aim of this review is to provide an overview of what is currently known about truncal acne, its prevalence, aetiology and physiopathology, how its severity is currently evaluated, how to differentiate it from other skin afflictions and current treatment options. A review of literature considering the issue of truncal acne published up to 2019 and available from PubMed was conducted, and in total, 76 articles were selected from PubMed. Currently, only little information about truncal acne is available. Considered as having the same pathophysiology as facial acne, the clinical picture and treatment response seem to differ. Specific acne severity grading systems and quality of life questionnaires as well as a specific treatment algorithm are still lacking. Filling this gap should allow clinicians to assess truncal acne in the best possible way, choosing suitable treatment options, helping patients to improve treatment adherence and quality of life and finally allowing a better management of truncal acne. In conclusion, more knowledge is required to treat more efficiently truncal acne.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2241-2246Subventions
Organisme : Galderma
Informations de copyright
© 2020 European Academy of Dermatology and Venereology.
Références
Nast A, Dreno B, Bettoli V et al. European evidence-based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol 2012; 26(Suppl 1): 1-29.
Del Rosso JQ. Management of truncal acne vulgaris: current perspectives on treatment. Cutis 2006; 77: 285-289.
Tan JK, Tang J, Fung K et al. Prevalence and severity of facial and truncal acne in a referral cohort. J Drugs Dermatol 2008; 7: 551-556.
Tan J, Thiboutot D, Popp G et al. Randomized phase 3 evaluation of trifarotene 50 mug/g cream treatment of moderate facial and truncal acne. J Am Acad Dermatol 2019; 80: 1691-1699.
Wolkenstein P, Loundou A, Barrau K, Auquier P, Revuz J. Quality of life impairment in hidradenitis suppurativa: a study of 61 cases. J Am Acad Dermatol 2007; 56: 621-623.
Mallon E, Newton JN, Klassen A, Stewart-Brown SL, Ryan TJ, Finlay AY. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol 1999; 140: 672-676.
Tan JK, Tang J, Fung K et al. Development and validation of a Scale for Acne Scar Severity (SCAR-S) of the face and trunk. J Cutan Med Surg 2010; 14: 156-160.
Hosthota A, Bondade S, Basavaraja V. Impact of acne vulgaris on quality of life and self-esteem. Cutis 2016; 98: 121-124.
Soliman YS, Horowitz R, Hashim PW, Nia JK, Farberg AS, Goldenberg G. Update on acne scar treatment. Cutis 2018; 102: 21; 5; 47; 8.
Del Rosso JQ, Bikowski JB, Baum E et al. A closer look at truncal acne vulgaris: prevalence, severity, and clinical significance. J Drugs Dermatol 2007; 6: 597-600.
Isaacsson VC, Almeida HL Jr, Duquia RP, Breunig Jde A, Souza PR. Dissatisfaction and acne vulgaris in male adolescents and associated factors. An Bras Dermatol 2014; 89: 576-579.
Goncalves G, Amado JM, Matos ME, Massa A. The prevalence of acne among a group of Portuguese medical students. J Eur Acad Dermatol Venereol 2012; 26: 514-517.
Dreno B, Thiboutot D, Layton AM, Berson D, Perez M, Kang S. Large-scale international study enhances understanding of an emerging acne population: adult females. J Eur Acad Dermatol Venereol. 2015; 29:1096-1106.
Dreno B, Jean-Decoster C, Georgescu V. Profile of patients with mild-to-moderate acne in Europe: a survey. Eur J Dermatol 2016; 26: 177-184.
Gollnick HP. From new findings in acne pathogenesis to new approaches in treatment. J Eur Acad Dermatol Venereol 2015; 29(Suppl 5): 1-7.
Kircik LH. Advances in the understanding of the pathogenesis of inflammatory acne. J Drugs Dermatol. 2016; 15(1 Suppl 1): s7-s10.
Kim BR, Chun MY, Kim SA, Youn SW. Sebum secretion of the trunk and the development of truncal acne in women: do truncal acne and sebum affect each other? Dermatology 2015; 231: 87-93.
Dagnelie MA, Corvec S, Saint-Jean M et al. Decrease in diversity of propionibacterium acnes phylotypes in patients with severe acne on the back. Acta Derm Venereol 2018; 98: 262-267.
Dagnelie MA, Corvec S, Saint-Jean M, Nguyen JM, Khammari A, Dreno B. Cutibacterium acnes phylotypes diversity loss: a trigger for skin inflammatory process. J Eur Acad Dermatol Venereol 2019; 33: 2340-2348.
Saint-Jean M, Khammari A, Jasson F, Nguyen JM, Dréno B. Different cutaneous innate immunity profiles in acne patients with and without atrophic scars. Eur J Dermatol 2016; 26: 68-74.
Dreno B, Bettoli V, Araviiskaia E, Sanchez Viera M, Bouloc A. The influence of exposome on acne. J Eur Acad Dermatol Venereol 2018; 32: 812-819.
Claudel JP, Auffret N, Leccia MT, Poli F, Dreno B. Acne and nutrition: hypotheses, myths and facts. J Eur Acad Dermatol Venereol 2018; 32: 1631-1637.
Dreno B, Bettoli V, Perez M, Bouloc A, Ochsendorf F. Cutaneous lesions caused by mechanical injury. Eur J Dermatol 2015; 25: 114-121.
Cengiz FP, Cevirgen Cemil B, Emiroglu N, Gulsel Bahali A, Onsun N. Acne located on the trunk, whey protein supplementation: is there any association? Health Promot Perspect 2017; 7: 106-108.
Short RW, Agredano YZ, Choi JM, Kimball AB. A single-blinded, randomized pilot study to evaluate the effect of exercise-induced sweat on truncal acne. Pediatr Dermatol 2008; 25: 126-128.
Deplewski D, Rosenfield RL. Role of hormones in pilosebaceous unit development. Endocr Rev 2000; 21: 363-392.
Smith RN, Mann NJ, Braue A, Makelainen H, Varigos GA. The effect of a high-protein, low glycemic-load diet versus a conventional, high glycemic-load diet on biochemical parameters associated with acne vulgaris: a randomized, investigator-masked, controlled trial. J Am Acad Dermatol 2007; 57: 247-256.
Motosko CC, Zakhem GA, Pomeranz MK, Hazen A. Acne: a side-effect of masculinizing hormonal therapy in transgender patients. Br J Dermatol 2019; 180: 26-30.
Turrion-Merino L, Urech-Garcia-de-la-Vega M, Miguel-Gomez L, Harto-Castano A, Jaen-Olasolo P. Severe acne in female-to-male transgender patients. JAMA Dermatol 2015; 151: 1260-1261.
Cunliffe WJ, Holland DB, Clark SM, Stables GI. Comedogenesis: some new aetiological, clinical and therapeutic strategies. Br J Dermatol 2000; 142: 1084-1091.
Hafsi W, Badri T. Acne Conglobata. StatPearls. StatPearls Publishing LLC, Treasure Island, 2019.
Melnik B, Jansen T, Grabbe S. Abuse of anabolic-androgenic steroids and bodybuilding acne: an underestimated health problem. J Dtsch Dermatol Ges 2007; 5: 110-117.
Gualtieri B, Tonini A, Panduri S, Chiricozzi A, Romanelli M. Acne fulminans associated with lymecycline intake: a case report. Clin Cosmet Investig Dermatol 2018; 11: 403-405.
Li AW, Antaya RJ. Isotretinoin-induced acne fulminans without systemic symptoms with concurrent exuberant granulation tissue. Pediatr Dermatol 2018; 35: 257-258.
Alakeel A, Ferneiny M, Auffret N, Bodemer C. Acne fulminans: case series and review of the literature. Pediatr Dermatol 2016; 33: e388-e392.
Martin AR, Lookingbill DP, Botek A, Light J, Thiboutot D, Girman CJ. Health-related quality of life among patients with facial acne - assessment of a new acne-specific questionnaire. Clin Exp Dermatol 2001; 26: 380-385.
Richter C, Trojahn C, Hillmann K et al. Sensitivity to change of the Dermatology Life Quality Index in adult females with facial acne vulgaris: a validation study. J Eur Acad Dermatol Venereol 2017; 31: 169-174.
Salman A, Kurt E, Topcuoglu V, Demircay Z. Social anxiety and quality of life in Vitiligo and acne patients with facial involvement: a cross-sectional controlled study. Am J Clin Dermatol 2016; 17: 305-311.
McLellan C, Frey MP, Tan J. Assessing the need for a comprehensive acne quality-of-life scale for face and torso acne. J Cutan Med Surg 2018; 22: 263-266.
Pillsbury DM, Shelley WB. Dermatology. Annu Rev Med 1954; 5: 363-388.
Burke BM, Cunliffe WJ. The assessment of acne vulgaris-the Leeds technique. Br J Dermatol 1984; 111: 83-92.
Dreno B, Bodokh I, Chivot M et al. [ECLA grading: a system of acne classification for every day dermatological practice]. Ann Dermatol Venereol 1999; 126:136-141.
Tan JK, Tang J, Fung K et al. Development and validation of a comprehensive acne severity scale. J Cutan Med Surg 2007; 11: 211-216.
Bernardis E, Shou H, Barbieri JS et al. Development and Initial validation of a multidimensional acne global grading system integrating primary lesions and secondary changes. JAMA Dermatol 2020; 156: 296-302.
Prindaville B, Belazarian L, Levin NA, Wiss K. Pityrosporum folliculitis: a retrospective review of 110 cases. J Am Acad Dermatol 2018; 78: 511-514.
Rubenstein RM, Malerich SA. Malassezia (pityrosporum) folliculitis. J Clin Aesthet Dermatol 2014; 7: 37-41.
Poli F. Differential diagnosis of facial acne on black skin. Int J Dermatol 2012; 51(Suppl 1): 24-26, 7-9.
Revuz JE, Canoui-Poitrine F, Wolkenstein P et al. Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. J Am Acad Dermatol 2008; 59: 596-601.
Dreno B, Khammari A, Brocard A et al. Hidradenitis suppurativa: the role of deficient cutaneous innate immunity. Arch Dermatol 2012; 148: 182-186.
Revuz JE, Jemec GB. Diagnosing Hidradenitis Suppurativa. Dermatol Clin 2016; 34: 1-5.
Poli F, Revuz J. [Acne flare on isotretinoin: A pointer to diagnosis of hidradenitis suppurativa]. Ann Dermatol Venereol 2019; 146: 4-8.
van der Zee HH, de Ruiter L, Boer J et al. Alterations in leucocyte subsets and histomorphology in normal-appearing perilesional skin and early and chronic hidradenitis suppurativa lesions. Br J Dermatol 2012; 166: 98-106.
Kazandjieva J, Tsankov N. Drug-induced acne. Clin Dermatol 2017; 35: 156-162.
Plewig G, Jansen T. Acneiform dermatoses. Dermatology 1998; 196: 102-107.
Nast A, Dreno B, Bettoli V et al. European evidence-based (S3) guideline for the treatment of acne - update 2016 - short version. J Eur Acad Dermatol Venereol 2016; 30: 1261-1268.
Zaenglein AL, Pathy AL, Schlosser BJ et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol 2016; 74: 945-973.e33.
Thiboutot D, Gollnick H, Bettoli V et al. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. J Am Acad Dermatol 2009; 60(5 Suppl): S1-S50.
Thiboutot DM, Dreno B, Abanmi A et al. Practical management of acne for clinicians: an international consensus from the Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 2018; 78: S1-S23.e1.
Greywal T, Zaenglein AL, Baldwin HE et al. Evidence-based recommendations for the management of acne fulminans and its variants. J Am Acad Dermatol 2017; 77: 109-117.
Schaunig C, Kopera D. Silk textile with antimicrobial AEM5772/5 (Dermasilk): a pilot study with positive influence on acne vulgaris on the back. Int J Dermatol 2017; 56: 589-591.
Leyden JJ. Efficacy of benzoyl peroxide (5.3%) emollient foam and benzoyl peroxide (8%) wash in reducing Propionibacterium acnes on the back. J Drugs Dermatol 2010; 9: 622-625.
Yew YW, Lai YC, Lim YL, Chong WS, Theng C. Photodynamic therapy with topical 5% 5-aminolevulinic acid for the treatment of truncal acne in asian patients. J Drugs Dermatol 2016; 15: 727-732.
Palli MB, Reyes-Habito CM, Lima XT, Kimball AB. A single-center, randomized double-blind, parallel-group study to examine the safety and efficacy of 3mg drospirenone/0.02 mg ethinyl estradiol compared with placebo in the treatment of moderate truncal acne vulgaris. J Drugs Dermatol 2013; 12: 633-637.
Leyden JJ, Del Rosso JQ. The effect of benzoyl peroxide 9.8% emollient foam on reduction of Propionibacterium acnes on the back using a short contact therapy approach. J Drugs Dermatol 2012; 11: 830-833.
Del Rosso JQ, Kircik L, Tanghetti E. Management of truncal acne vulgaris with topical dapsone 7.5% gel. J Clin Aesthet Dermatol 2018; 11: 45-50.
Hoffman LK, Del Rosso JQ, Kircik LH. The efficacy and safety of azelaic acid 15% foam in the treatment of truncal acne vulgaris. J Drugs Dermatol 2017; 16: 534-538.
Moftah NH, Ibrahim SM, Wahba NH. Intense pulsed light versus photodynamic therapy using liposomal methylene blue gel for the treatment of truncal acne vulgaris: a comparative randomized split body study. Arch Dermatol Res 2016; 308: 263-268.
Cunliffe WJ. Evolution of a strategy for the treatment of acne. J Am Acad Dermatol 1987; 16(3 Pt 1): 591-599.
Del Rosso JQ. Truncal acne vulgaris: the relative roles of topical and systemic antibiotic therapy. J Drugs Dermatol 2007; 6: 148-151.
Bikowski J, Callender VD, Del Rosso JQ, Draelos ZD, Tanghetti E. Combining clindamycin 1%-benzoyl peroxide 5% gel with multiple therapeutic options. Cutis 2006; 78(2 Suppl 1): 13-20.
Isvy-Joubert A, Nguyen JM, Gaultier A et al. Adult female acne treated with spironolactone: a retrospective data review of 70 cases. Eur J Dermatol 2017; 27: 393-398.
Sand FL, Thomsen SF. Adalimumab for the treatment of refractory acne conglobata. JAMA Dermatol 2013; 149: 1306-1307.
Yiu ZZ, Madan V, Griffiths CE. Acne conglobata and adalimumab: use of tumour necrosis factor-alpha antagonists in treatment-resistant acne conglobata, and review of the literature. Clin Exp Dermatol 2015; 40: 383-386.
Balakirski G, Neis MM, Megahed M. Acne conglobata induced by adalimumab. Eur J Dermatol 2017; 27: 320-321.
Borgia F, Vaccaro M, Giuffrida R, Cannavo SP. Photodynamic therapy for acne conglobata of the buttocks: Effective antiinflammatory treatment with good cosmetic outcome. Indian J Dermatol Venereol Leprol 2018; 84: 617-619.
Myers JN, Mason AR, Gillespie LK, Salkey KS. Treatment of acne conglobata with modern external beam radiation. J Am Acad Dermatol 2010; 62: 861-863.
Shirakawa M, Uramoto K, Harada FA. Treatment of acne conglobata with infliximab. J Am Acad Dermatol 2006; 55: 344-346.
Choi JM, Lew VK, Kimball AB. A single-blinded, randomized, controlled clinical trial evaluating the effect of face washing on acne vulgaris. Pediatr Dermatol 2006; 23: 421-427.
Goodman G. Cleansing and moisturizing in acne patients. Am J Clin Dermatol 2009; 10(Suppl 1): 1-6.